Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

SALT LAKE CITY and BOCA RATON, Fla. – May 15, 2023 – Nusano , Inc., a company reshaping the production of cancer-fighting radioisotopes, and PharmaLogic Holdings Corp. , a world-class contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, today announced the two organizations will collaborate to advance the development of radiopharmaceuticals for diagnostic and therapeutic applications.